Stay updated on Pepinemab for Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pepinemab for Pediatric Solid Tumors Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2Fet-TKccqJHBnquauwGRdbb54QrY.uncropped.jpg&w=3840&q=75)
Latest updates to the Pepinemab for Pediatric Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version 2.10.0, adding 3 more study numbers and indicating that the study now has 24 locations, while the previous version 2.9.7 has been removed.SummaryDifference0.4%
- Check5 days agoNo Change Detected
- Check10 days agoChange DetectedThe website now displays the actual last update posted instead of an estimated time, providing users with more accurate information.SummaryDifference0.0%
- Check11 days agoChange DetectedThe website has been updated with completed information for 2024, including the last update posted (estimated) in July 2024 and revision v2.9.7, while removing outdated details from 2023 and earlier revisions.SummaryDifference1.0%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the web page content.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.SummaryDifference0.1%
Stay in the know with updates to Pepinemab for Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pepinemab for Pediatric Solid Tumors Clinical Trial page.